Distribution and impact of p16 INK4A+ senescent cells in elderly tissues: a focus on senescent immune cell and epithelial dysfunction.
Level 5 - mechanism / opinion, no new human data
Preclinical laboratory and mechanistic tissue study without clinical outcome data
PubMed 39617789 · doi:10.1038/s12276-024-01354-4
What was done
The authors examined the distribution of p16 INK4A+ fully senescent cells across young and aged normal organ tissues, evaluating parenchymal cells, structural stromal cells (such as fibroblasts and smooth muscle cells), and immune cells. They also investigated the downstream effects of p16 INK4A+ senescent T cells on colonic epithelial cell viability, inflammation, and barrier integrity, focusing on Granzyme A-PARs pathway signaling.
What was found
The abstract reports no numerical metrics or statistical values. p16 INK4A+ senescent cells were rarely observed in organ parenchyma or structural stroma, but were predominantly identified among resident and infiltrating immune cells. Furthermore, p16 INK4A+ senescent T cells directly promoted apoptosis and inflammation in colonic epithelial cells through Granzyme A-PARs signaling, impairing the epithelial barrier.
Why it matters
These findings suggest that tissue-level aging phenotypes and barrier breakdown can be driven non-autonomously by senescent immune cells rather than primary parenchymal senescence. This highlights immunosenescence and Granzyme A-PARs signaling as potential therapeutic targets for age-related epithelial dysfunction.
Limits
The abstract provides no sample sizes, numerical effect estimates, or details on whether the tissues studied were human or animal. Functional in vivo therapeutic interventions were not reported in the abstract.
Cited by
- context Senescent cells are rare in human tissues before age 50 or 60 and become detectable after the midpoint of lifespan.